Clinical Trials

56 enrolled

Non-small Cell Lung Cancer Metastatic

NCT07398599 2026-04-23

Double-Dose Third-Generation EGFR-TKI Plus Bevacizumab and Intrathecal Chemotherapy for Refractory Leptomeningeal Metastatic NSCLC: A Phase II Study

Phase NA Not yet recruiting

30 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Meningeal Carcinomatosis

NCT07543510 2026-04-22

Low-Dose Bevacizumab and Atezolizumab Combined With TACE-HAIC in Unresectable Hepatocellular Carcinoma

38 enrolled

Carcinoma, Hepatocellular

NCT04180072 2026-04-09

Atezolizumab Plus Bevacizumab With HCC and HBV Infection

51 enrolled

Carcinoma, Hepatocellular

NCT04446416 2026-04-09

Efficacy and Safety of NaviFUS System add-on Bevacizumab (BEV) in Recurrent GBM Patients

6 enrolled

Brain Neoplasms, Glioblastoma, Glioma, Neoplasms, Neoplasms, Nerve Tissue

NCT02698254 2026-01-07

Radiation Therapy in Treating Patients With Recurrent Brain Tumors Who Have Undergone Previous Radiation Therapy

40 enrolled

Phase NA Not yet recruiting

Brain Neoplasms

NCT07281664 2025-12-15

Transarterial Chemoembolization With Low-Dose Bevacizumab Plus Atezolizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

30 enrolled

Carcinoma, Hepatocellular

NCT07272265 2025-12-09

The Effectiveness and Safety in High-risk Patients Receiving First-line Atezolizumab and Bevacizumab Combined With HAIC for HCC: a Retrospective Study

300 enrolled

Carcinoma, Hepatocellular

NCT03698162 2025-08-05

Precise DCE-MRI in Diagnosing Participants With Recurrent High Grade Glioma or Melanoma Brain Metastases

15 enrolled

CNSDermatologic

Brain Neoplasms, Melanoma

NCT05284643 2025-08-01

Spectroscopic MRI, Proton Therapy, and Avastin for Recurrent Glioblastoma

96 enrolled

Brain Neoplasms, Glioblastoma

NCT06893887 2025-07-02

ICT-HCC

300 enrolled

Carcinoma, Hepatocellular

NCT06292286 2025-06-11

SCENIC

18 enrolled

Gynecologic

Ovarian Neoplasms

NCT01792934 2025-04-15

ORCHESTRA

478 enrolled

Multi-organ Metastatic Colorectal Cancer

NCT06643000 2025-03-06

Evaluating High-dose Furmonertinib with Bevacizumab and Pemetrexed for EGFRm NSCLC with Leptomeningeal Metastasis

60 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT05984511 2025-02-11

TACE Plus Atezolizumab/Bevacizumab and I-125 Seeds Brachytherapy for HCC With Branch PVTT

234 enrolled

Carcinoma, Hepatocellular

NCT04973293 2024-11-19

Preoperative Sintilimab Combined With Bevacizumab and Chemotherapy for Resectable Non-Small Cell Lung Cancer

20 enrolled

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

NCT06265350 2024-02-20

Cryoablation Combined With Cardonilizumab and Bevacizumab in Hepatocellular Carcinoma With Pulmonary Metastases

80 enrolled

Carcinoma, Hepatocellular, Liver Neoplasms

NCT06177288 2023-12-20

DEBIRI

39 enrolled

Phase NA Not yet recruiting

Colorectal Neoplasms

NCT06035133 2023-09-13

Treatment of Low Locally Advanced Rectal Cancer With Radiotherapy Removal TNT Plus Neoadjuvant Therapy

213 enrolled

Rectal Neoplasms

NCT03743428 2023-06-29

BABST-C

Phase NA Suspended

40 enrolled

Colorectal Neoplasms

NCT05410301 2023-04-21

Golden Halo, Static Magnetic and Electric Field Device, in Recurrent Glioblastoma

Phase NA Withdrawn

Glioblastoma

NCT05811793 2023-04-13

Efficacy and Safety of SCAI of Bevacizumab Combined With IC of Tislelizumab in the Treatment of Recurrent Glioblastoma.

36 enrolled

Glioblastoma

NCT02256800 2021-11-17

Escalated Dose of Irinotecan in mCRC

213 enrolled

Colorectal Neoplasms

NCT02076152 2021-07-30

FMISO PET Study of Glioblastoma

11 enrolled 11 charts

Glioblastoma

NCT04944069 2021-06-29

ATTRACT

69 enrolled

CNSThoracic

Carcinoma, Non-Small-Cell Lung, Meningeal Carcinomatosis

NCT01201850 2021-05-19

The Role of Bevacizumab in the Treatment of Radiation Necrosis in Children With Central Nervous System Tumors

7 enrolled 8 charts

Central Nervous System Neoplasms

NCT01280643 2021-03-15

Combination Chemotherapy and Cetuximab or Bevacizumab in Treating Patients With Metastatic Colorectal Cancer

3 enrolled 8 charts

Colonic Neoplasms, Rectal Neoplasms, Colorectal Neoplasms

NCT01063283 2019-11-18

AVF4759

20 enrolled 9 charts

Advanced Non-squamous Non-Small Cell Lung Cancer

NCT00911716 2019-08-01

TC Avastin. ICORG 08-10, V6

106 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00499694 2018-06-12

Satraplatin and Bevacizumab in Treating Patients With Metastatic Prostate Cancer Previously Treated With Docetaxel

31 enrolled 8 charts

Genitourinary

Prostatic Neoplasms

NCT01223235 2018-06-12

Polyvalent Vaccine-KLH Conjugate + Opt-821 Given in Combination With Bevacizumab

22 enrolled 10 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01834014 2017-08-02

ATOM ES

110 enrolled

Colorectal Neoplasms

NCT00595322 2017-05-23

Bevacizumab in the Radiation Treatment of Recurrent Malignant Glioma

25 enrolled

Brain Neoplasms, Glioma

NCT01836536 2017-03-01

AVA-CELL

30 enrolled

Glioblastoma, Glioma

NCT02841332 2016-12-20

IMAGLIO

6 enrolled

Glioblastoma

NCT00596362 2016-06-17

Treatment With Intravitreal Avastin for Large Uveal Melanomas

1 enrolled 3 charts

Dermatologic

Uveal Melanoma, Melanoma

NCT01939574 2016-01-21

A Explore Study of Bevacizumab Combined With Conventional Therapy in Glioblastoma

20 enrolled

Glioblastoma

NCT00462501 2016-01-20

Combination Chemotherapy and Bevacizumab With or Without Radiation Therapy in Treating Patients With Locally Advanced Rectal Cancer

35 enrolled 6 charts

Rectal Neoplasms, Colorectal Neoplasms

NCT00537901 2015-12-17

First-Line Bevacizumab and Chemotherapy in Metastatic Cancer of the Colon or Rectum - International Study

100 enrolled

Colonic Neoplasms, Rectal Neoplasms

NCT00675597 2015-11-20

Docetaxel (Taxotere), Vinorelbine, and Bevacizumab, as Adjuvant Chemotherapy for Patients With Resected Stage I-III Non-small Cell Lung Cancer

25 enrolled 6 charts

Lung Neoplasms

NCT01405430 2015-06-29

AVECC

63 enrolled

Neoplasm Metastasis, Colorectal Neoplasms

NCT00826800 2015-04-15

Neoadjuvant FOLFOX Plus Bevacizumab Chemotherapy in Patients With Locally Advanced Colon Cancer

2 enrolled 4 charts

Colonic Neoplasms

NCT02208128 2014-08-04

MORE

4 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT02195336 2014-07-21

BevMar

20 enrolled

Carcinoma, Non-Small-Cell Lung

NCT01017250 2014-02-28

Radiosurgery and Avastin for Recurrent Malignant Gliomas

15 enrolled 23 charts

Glioma, Recurrence

NCT00436709 2014-01-06

Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer

75 enrolled

Breast

Breast Neoplasms, Breast Neoplasms, Male

NCT00121134 2013-12-24

Bevacizumab With or Without Cyclophosphamide and Methotrexate: A Pilot Study in Women With Operable Breast Cancer

164 enrolled 9 charts

Breast

Breast Neoplasms

NCT00602862 2013-12-02

Effect of Sorafenib on ccRCC Uptake of Radiolabeled Bevacizumab or cG250

26 enrolled

Genitourinary

Carcinoma, Renal Cell

NCT00524069 2013-02-01

Gemcitabine, Capecitabine, and Bevacizumab in Treating Patients With Pancreatic Cancer That Can Be Removed By Surgery

Phase NA Withdrawn